These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 26813303
1. Production, Characterization and Evaluation of Kaempferol Nanosuspension for Improving Oral Bioavailability. Qian YS, Ramamurthy S, Candasamy M, Shadab M, Kumar RH, Meka VS. Curr Pharm Biotechnol; 2016; 17(6):549-55. PubMed ID: 26813303 [Abstract] [Full Text] [Related]
2. Solid Dispersion of Kaempferol: Formulation Development, Characterization, and Oral Bioavailability Assessment. Colombo M, de Lima Melchiades G, Michels LR, Figueiró F, Bassani VL, Teixeira HF, Koester LS. AAPS PharmSciTech; 2019 Feb 11; 20(3):106. PubMed ID: 30746582 [Abstract] [Full Text] [Related]
4. A phospholipid complex to improve the oral bioavailability of flavonoids. Wang H, Cui Y, Fu Q, Deng B, Li G, Yang J, Wu T, Xie Y. Drug Dev Ind Pharm; 2015 Feb 11; 41(10):1693-703. PubMed ID: 25496311 [Abstract] [Full Text] [Related]
5. Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability. Singh MK, Pooja D, Ravuri HG, Gunukula A, Kulhari H, Sistla R. Phytomedicine; 2018 Feb 01; 40():48-54. PubMed ID: 29496174 [Abstract] [Full Text] [Related]
6. Fabrication of Nanosuspension Directly Loaded Fast-Dissolving Films for Enhanced Oral Bioavailability of Olmesartan Medoxomil: In Vitro Characterization and Pharmacokinetic Evaluation in Healthy Human Volunteers. Alsofany JM, Hamza MY, Abdelbary AA. AAPS PharmSciTech; 2018 Jul 01; 19(5):2118-2132. PubMed ID: 29700766 [Abstract] [Full Text] [Related]
10. Pharmacokinetic evaluation of the interaction between oral kaempferol and ethanol in rats. Zhou Z, Wang M, Guo Z, Zhang X. Acta Pharm; 2016 Dec 01; 66(4):563-568. PubMed ID: 27749255 [Abstract] [Full Text] [Related]
11. Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability. Nagaraj K, Narendar D, Kishan V. Drug Dev Ind Pharm; 2017 Jul 01; 43(7):1186-1196. PubMed ID: 28271908 [Abstract] [Full Text] [Related]
15. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension. Ahuja BK, Jena SK, Paidi SK, Bagri S, Suresh S. Int J Pharm; 2015 Jan 30; 478(2):540-52. PubMed ID: 25490182 [Abstract] [Full Text] [Related]
16. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation. Hong C, Dang Y, Lin G, Yao Y, Li G, Ji G, Shen H, Xie Y. Int J Pharm; 2014 Dec 30; 477(1-2):251-60. PubMed ID: 25445518 [Abstract] [Full Text] [Related]
17. Physicochemical, Pharmacodynamic and Pharmacokinetic Characterization of Soluplus Stabilized Nanosuspension of Tacrolimus. Varshosaz J, Minayian M, Yazdekhasti S. Curr Drug Deliv; 2017 Dec 30; 14(4):521-535. PubMed ID: 27697037 [Abstract] [Full Text] [Related]
18. Phytic acid enhances the oral absorption of isorhamnetin, quercetin, and kaempferol in total flavones of Hippophae rhamnoides L. Xie Y, Luo H, Duan J, Hong C, Ma P, Li G, Zhang T, Wu T, Ji G. Fitoterapia; 2014 Mar 30; 93():216-25. PubMed ID: 24462958 [Abstract] [Full Text] [Related]
19. Development of nanosuspension formulation for oral delivery of quercetin. Sun M, Gao Y, Pei Y, Guo C, Li H, Cao F, Yu A, Zhai G. J Biomed Nanotechnol; 2010 Aug 30; 6(4):325-32. PubMed ID: 21323105 [Abstract] [Full Text] [Related]